Clinical pharmacology of cholecystokinin--pancreozymin
Geller, L.I.
Klinicheskaia Meditsina 54(3): 23-29
1976
ISSN/ISBN: 0023-2149 PMID: 966653 Document Number: 97526
Document emailed within 1 workday
Related Documents
Iwata, Y.; Arakawa, T.; Kuroki, T.; Kobayashi, K. 1999: Cholecystokinin.pancreozymin (CCK-PZ) Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 332-334Schlegel, W.; Grube, D. 1978: Radioimmunoassay [RIA] of cholecystokinin-pancreozymin [33-CCK Zeitschrift für Gastroenterologie 16(5): 304-310
Darmostuk, V.I. 1977: Use of cholecystokinin pancreozymin in treatment of some pancreobiliary system diseases Vrachebnoe Delo 5: 28-32
Holtermüller, K.H.; McCall, J.T.; Malagelada, J.R.; Go, V.L. 1974: Intraduodenal calcium stimulates liberation of cholecystokinin-pancreozymin (CCK-PZ) in man Verhandlungen der Deutschen Gesellschaft für Innere Medizin 80: 536-537
Kanno, T.; Saito, A.; Yonezawa, H. 1980: Unidirectional cellular processes of stimulus-secretion coupling in a cell secreting cholecystokinin-pancreozymin Advances in Biochemical Psychopharmacology 25: 327-332
Batt, R.A. 1983: Decreased food intake in response to cholecystokinin (pancreozymin) in wild-type and obese mice (genotype ob/ob) International Journal of Obesity 7(1): 25-29
Loginov, A.S.; Goriacheva, T.V. 1982: Participation of cGMP in realizing the effect of cholecystokinin-pancreozymin on the bile-excreting function of the human liver Biulleten' Eksperimental'noi Biologii i Meditsiny 94(8): 8-11
Lankisch, P.G.; Fölsch, U.R.; Köstering, H.; Creutzfeldt, W. 1976: Inhibition by somatostatin of pancreatic juice and enzyme secretion and gallbladder contraction induced by secretin, cholecystokinin-pancreozymin and carbachol administration Zeitschrift für Gastroenterologie. Verhandlungsband 10: 51-55
Vyas, B. 2001: European Association of Clinical Pharmacology and Therapeutics--Fifth Congress. Clinical pharmacology: from molecule to society--bridging the gap via Man IDrugs: the investigational drugs journal 4(10): 1133-1137
Poulsen, H.Enghusen.; Schmitz, O.E.; Brøsen, K. 2002: Clinical pharmacology 2001--important events. The Danish Society of Clinical Pharmacology Ugeskrift for laeger 164(12): 1652
Duchêne-Marullaz, P. 1977: Pharmacology, clinical pharmacology and therapeutic effects of Royat's thermal gas Semaine des Hopitaux. Therapeutique 53(7-8): 361-362
Rodriguez, M.; Lignon, M.F.; Galas, M.C.; Amblard, M.; Martinez, J. 1990: Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors Molecular Pharmacology 38(3): 333-341
Lilja, P.; Fagan, C.J.; Wiener, I.; Inoue, K.; Watson, L.C.; Rayford, P.L.; Thompson, J.C. 1982: Infusion of pure cholecystokinin in humans. Correlation between plasma concentrations of cholecystokinin and gallbladder size Gastroenterology 83(1 Pt 2): 256-261
Nathan, M.H.; Newman, A. 1974: Present status of cholecystokinin cholecystography in clinical practice Arizona Medicine 31(9): 655-656
Demchenko, V.T.; Kantariia, V.A.; Kerimov, B.L.; Shogentsukova, E.A.; Shomakhova, N.S. 1984: Clinical pharmacology and clinical pharmacy in a general clinical hospital Sovetskoe Zdravookhranenie 9: 27-29
Moiseev, V.S.; Lepakhin, V.K. 1989: Clinical pharmacology and problems of drug therapy in the clinical picture of internal diseases Terapevticheskii Arkhiv 61(8): 6-10
Simić, D.; Vrhovac, B. 1978: Clinical pharmacology: its importance, place, and role in larger clinical centers Medicinski Pregled 31(9-10): 403-408
Brandão, F.; Polónia, J. 1992: Clinical trials in cardiovascular clinical pharmacology Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(3): 273-281
Lunde, P.K. 1970: Clinical pharmacology Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 90(24): 2282-2284
Giudicelli, J.F. 1985: Clinical pharmacology of enalapril Presse Medicale 14(44): 2209-2211